EUVIMEDEUVIMED entdecken
Crossref

S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題

泉 吾妻

Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku · 2025 · 30 (Supplement) · S109-S109

DOI: 10.3820/jjpe.30.s109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 2025. Verfasst von 泉 吾妻.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

吾妻, 泉. (2025). S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, 30(Supplement), S109-S109. https://doi.org/10.3820/jjpe.30.s109

Vancouver

吾妻 泉. S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題. Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku. 2025;30(Supplement):S109-S109. doi:10.3820/jjpe.30.s109

BibTeX
@article{2025,
  author = {吾妻, 泉},
  title = {S4-5 RevMate®に基づくレナリドミド後発品の安全対策の現状と課題},
  journal = {Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku},
  year = {2025},
  volume = {30},
  number = {Supplement},
  pages = {S109--S109},
  doi = {10.3820/jjpe.30.s109}
}
Kostenlos starten →